Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: Results of a survey of long-term care practitioners

Journal of the American Geriatrics Society

Volumn 45, Issue 9, 1997, Pages 1060-1065

  Monette, Johanne ^b   Gurwitz, Jerry H ^a   Rochon, Paula A ^b   Avorn, Jerry ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ARTICLE; BLEEDING TENDENCY; COMPLICATION; FALLING; HEALTH CARE QUALITY; HEALTH SURVEY; HEART ATRIUM FIBRILLATION; HUMAN; LONG TERM CARE; PATIENT ATTITUDE; PREVALENCE; RISK ASSESSMENT; STROKE; TREATMENT INDICATION;

EID: 0030763778     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb05967.x     Document Type: Article

References (29)

1. Kemper P, Murtaugh CM. Lifetime use of nursing home care. N Engl J Med 1991;324:595-600.
2. Feinberg WM, Blackshear JL, Laupacis A et al. Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implications. Arch Intern Med 1995;155:469-473.
3. Lackner TE, Battis GN. Use of warfarin for nonvalvular atrial fibrillation in nursing home patients. Arch Fam Med 1995;4:1017-1026.
4. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: A major contributor to stroke in the elderly: The Framingham Study. Arch Intern Med 1987;147:1561-1564.
5. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
6. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of anti-thrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
7. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-1511.
8. 7a. Gurwitz JH, Monette J, Rochon PA et al. Atrial fibrillation and stroke prevention in the long-term care setting. Arch Intern Med 1997;157:978-984.
9. Chang HJ, Bell JR, Deroo DB et al. Physician variation in anticoagulating patients with atrial fibrillation. Arch Intern Med 1990;150:81-84.
10. Bucknall CA, Morris GK, Mitchell JRA. Physicians' attitudes to four common problems: Hypertension, atrial fibrillation, transjent ischaemic attacks, and angina pectoris. Br Med J 1986;293:739-742.
11. Kutner M, Nixon G, Silverstone F. Physicians' attitudes toward oral anticoagulants and antiplatelet agents for stroke prevention in elderly patients with atrial fibrillation. Arch Intern Med 1991;151:1950-1953.
12. Dow L, Bertagne B. Underuse of warfarin is multifactorial. Br Med J 1993;307:1492-1493.
13. King D, Davies KN. Doctors reluctant despite evidence. Br Med J 1993;307:1494.
14. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy. Am J Med 1989;87:144-152.
15. Petitti DB, Strom BL, Melmon KL. Prothrombin time ration and other factors associated with bleeding in patients treated with warfarin. J Clin Epidemiol 1989;42:759-764.
16. Launbjerg J, Egeblad H, Heaf J et al. Bleeding complications to anticoagulant therapy: Multivariate analysis of 1010 treatment years in 551 outpatients. J Intern Med 1991;229:351-355.
17. Gurwitz JH, Goldberg RJ, Holden A et al. Age-related risks of long-term anticoagulant therapy. Arch Intern Med 1988;148:1733-1736.
18. Fihn SD, McDonell M, Martin D et al. Risk factors for complications of chronic anticoagulation. A multicenter study. Warfarin-Optimized Outpatient Follow-up Study Group. Ann Intern Med 1993;118:511-520.
19. White RH, McKittrick T, Takakuwa J et al. Management and prognosis of life-threatening bleeding during warfarin therapy. Arch Intern Med 1996;156:1197-1201.
20. Fihn SD, Callahan CM, Martin DC et al. The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med 1996;124:970-979.
21. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994;120:897-902.
22. Laupacis A, Albers G, Dalen J et al. Antithrombotic therapy in atrial fibrillation. Chest 1995;108(suppl 4):352-359S.
23. Levine MN, Raskob G, Landefeld S, Hirsh J. Hemorrhagic complications of anticoagulant treatment. Chest 1995;108(suppl 4):276-290S.
24. The European Atrial Fibrillation Trial Study Group. Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med 1995;333:5-10.
25. Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation of patients with nonrheumatic atrial fibrillation. N Engl J Med 1996;335:540-546.
26. Rosendall FR. The Scylla and Charybdis of oral anticoagulant treatment. N Engl J Med 1996;335:587-589.
27. McCrory DC, Matchar DB, Samsa G et al. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med 1995;155:277-281.
28. Asch DA, Baron J, Mersey JC et al. Omission bias and pertussis vaccination. Med Decis Making 1994;14:118-123.
29. Singer DE. Anticoagulation to prevent stroke in atrial fibrillation. In: Di-Marco JP, Prystowsky EN, eds. Atrial Arrhythmias: State of the Art. Armonk, NY: Futura Publishing Company, 1995, pp 313-326. [app]